Back to search

National and Kapodistrian University of Athens

Προσδιορισμός των μεταλλάξεων του BRAF γονιδίου στον καρκίνο του παχέος εντέρου

Abstract

dc:description

Our aim was to evaluate the predictive and prognosticinfluence of BRAF mutation and other molecular, clinicaland laboratory parameters in stage IV colorectal cancer(CRC). 60 patients were included in this retrospective analysis,and 17 variables were examined for their relation withtreatment response and survival. KRAS mutation was identifiedin 40.3 % of cases, BRAF and PIK3CA in 8.8 % and10.5 % respectively. 29.8 % of patients responded to treatment.Median survival time was 14.3 months. Weight loss,fever, abdominal metastases, blood transfusion,hypoalbuminaimia, BRAF and PIK3CA mutations, CRP andDNA Index were associated with survival. In multivariateanalysis, male patients had 3.8 times higher probability ofresponse, increased DNA Index was inversely correlated withresponse and one unit raise of DNA Index augmented 6 timesthe probability of death. Our findings potentiate the prognosticrole of BRAF, PIK3CA mutations and ploidy in advancedCRC.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karadima, Maria
  • Καραδήμα, Μαρία

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/37953

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karadima, Maria; Καραδήμα, Μαρία. Προσδιορισμός των μεταλλάξεων του BRAF γονιδίου στον καρκίνο του παχέος εντέρου. National and Kapodistrian University of Athens, 2016. http://hdl.handle.net/10442/hedi/37953